![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ATP5MC3 |
Gene summary for ATP5MC3 |
![]() |
Gene information | Species | Human | Gene symbol | ATP5MC3 | Gene ID | 518 |
Gene name | ATP synthase membrane subunit c locus 3 | |
Gene Alias | ATP5G3 | |
Cytomap | 2q31.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | P48201 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
518 | ATP5MC3 | GSM4909281 | Human | Breast | IDC | 7.39e-43 | 8.60e-01 | 0.21 |
518 | ATP5MC3 | GSM4909282 | Human | Breast | IDC | 1.70e-81 | 1.03e+00 | -0.0288 |
518 | ATP5MC3 | GSM4909285 | Human | Breast | IDC | 3.25e-77 | 1.05e+00 | 0.21 |
518 | ATP5MC3 | GSM4909286 | Human | Breast | IDC | 3.47e-17 | 2.72e-01 | 0.1081 |
518 | ATP5MC3 | GSM4909287 | Human | Breast | IDC | 7.80e-43 | 8.39e-01 | 0.2057 |
518 | ATP5MC3 | GSM4909288 | Human | Breast | IDC | 6.13e-12 | 6.23e-01 | 0.0988 |
518 | ATP5MC3 | GSM4909289 | Human | Breast | IDC | 9.56e-06 | 5.95e-01 | 0.1064 |
518 | ATP5MC3 | GSM4909290 | Human | Breast | IDC | 6.19e-27 | 6.89e-01 | 0.2096 |
518 | ATP5MC3 | GSM4909291 | Human | Breast | IDC | 2.79e-19 | 6.28e-01 | 0.1753 |
518 | ATP5MC3 | GSM4909293 | Human | Breast | IDC | 4.32e-15 | 2.59e-01 | 0.1581 |
518 | ATP5MC3 | GSM4909294 | Human | Breast | IDC | 1.45e-14 | 5.14e-01 | 0.2022 |
518 | ATP5MC3 | GSM4909296 | Human | Breast | IDC | 1.39e-14 | 4.89e-01 | 0.1524 |
518 | ATP5MC3 | GSM4909297 | Human | Breast | IDC | 3.70e-04 | 3.06e-02 | 0.1517 |
518 | ATP5MC3 | GSM4909298 | Human | Breast | IDC | 5.05e-08 | 2.61e-01 | 0.1551 |
518 | ATP5MC3 | GSM4909301 | Human | Breast | IDC | 3.76e-04 | 3.56e-01 | 0.1577 |
518 | ATP5MC3 | GSM4909304 | Human | Breast | IDC | 1.57e-15 | 4.78e-01 | 0.1636 |
518 | ATP5MC3 | GSM4909305 | Human | Breast | IDC | 6.40e-12 | 3.71e-01 | 0.0436 |
518 | ATP5MC3 | GSM4909306 | Human | Breast | IDC | 3.82e-07 | 3.97e-01 | 0.1564 |
518 | ATP5MC3 | GSM4909307 | Human | Breast | IDC | 6.17e-13 | 5.41e-01 | 0.1569 |
518 | ATP5MC3 | GSM4909308 | Human | Breast | IDC | 1.29e-36 | 6.58e-01 | 0.158 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000914521 | Stomach | CSG | purine nucleoside triphosphate biosynthetic process | 22/1034 | 69/18723 | 8.34e-12 | 2.10e-09 | 22 |
GO:000675421 | Stomach | CSG | ATP biosynthetic process | 20/1034 | 57/18723 | 9.98e-12 | 2.40e-09 | 20 |
GO:000920121 | Stomach | CSG | ribonucleoside triphosphate biosynthetic process | 22/1034 | 74/18723 | 3.97e-11 | 8.40e-09 | 22 |
GO:000919921 | Stomach | CSG | ribonucleoside triphosphate metabolic process | 24/1034 | 89/18723 | 5.12e-11 | 1.00e-08 | 24 |
GO:000914221 | Stomach | CSG | nucleoside triphosphate biosynthetic process | 23/1034 | 85/18723 | 1.20e-10 | 2.21e-08 | 23 |
GO:000914121 | Stomach | CSG | nucleoside triphosphate metabolic process | 26/1034 | 112/18723 | 3.04e-10 | 4.87e-08 | 26 |
GO:000915221 | Stomach | CSG | purine ribonucleotide biosynthetic process | 28/1034 | 169/18723 | 1.72e-07 | 1.17e-05 | 28 |
GO:000915021 | Stomach | CSG | purine ribonucleotide metabolic process | 46/1034 | 368/18723 | 1.89e-07 | 1.26e-05 | 46 |
GO:000616321 | Stomach | CSG | purine nucleotide metabolic process | 48/1034 | 396/18723 | 2.61e-07 | 1.66e-05 | 48 |
GO:000925921 | Stomach | CSG | ribonucleotide metabolic process | 46/1034 | 385/18723 | 6.97e-07 | 3.75e-05 | 46 |
GO:000926021 | Stomach | CSG | ribonucleotide biosynthetic process | 28/1034 | 182/18723 | 8.22e-07 | 4.26e-05 | 28 |
GO:007252121 | Stomach | CSG | purine-containing compound metabolic process | 48/1034 | 416/18723 | 1.11e-06 | 5.64e-05 | 48 |
GO:001969321 | Stomach | CSG | ribose phosphate metabolic process | 46/1034 | 396/18723 | 1.54e-06 | 7.39e-05 | 46 |
GO:004639021 | Stomach | CSG | ribose phosphate biosynthetic process | 28/1034 | 190/18723 | 1.98e-06 | 9.02e-05 | 28 |
GO:000616421 | Stomach | CSG | purine nucleotide biosynthetic process | 28/1034 | 191/18723 | 2.20e-06 | 9.85e-05 | 28 |
GO:000911721 | Stomach | CSG | nucleotide metabolic process | 52/1034 | 489/18723 | 4.59e-06 | 1.84e-04 | 52 |
GO:007252221 | Stomach | CSG | purine-containing compound biosynthetic process | 28/1034 | 200/18723 | 5.46e-06 | 2.08e-04 | 28 |
GO:000675321 | Stomach | CSG | nucleoside phosphate metabolic process | 52/1034 | 497/18723 | 7.29e-06 | 2.62e-04 | 52 |
GO:000916521 | Stomach | CSG | nucleotide biosynthetic process | 31/1034 | 254/18723 | 2.93e-05 | 8.26e-04 | 31 |
GO:190129321 | Stomach | CSG | nucleoside phosphate biosynthetic process | 31/1034 | 256/18723 | 3.42e-05 | 9.31e-04 | 31 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501218 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502016 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501616 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019016 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501016 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501416 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520818 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471418 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541518 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
hsa0501219 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502017 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501617 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019017 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501017 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501417 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520819 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471419 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541519 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |